Logitech Q1 Beats, Boosts Revenue Outlook; Bullish Stance On Verrica Pharma
- July 25th, 2023
- 497 views
Logitech International S.A. (Nasdaq: LOGI) announced its first-quarter fiscal 2024 results, with earnings per share (EPS) of $0.65 and revenue of $974.5 million, surpassing the consensus estimate of $0.46 on revenue of $919.69 million.
Following this strong performance, Logitech has raised its outlook for the first half of Fiscal Year 2024. The company now expects revenue to be in the range of $1.875 billion to $1.975 billion, up from the previous range of $1.8 billion to $1.9 billion.
$LOGI is trading at $65.80 in pre-market, reflecting an increase of $2.84 (+4.51%).
In other news, Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a pharmaceutical company focused on developing medical solutions for various skin conditions, received a notable upgrade from Needham, who shifted its rating from Hold to Buy. In addition to the upgrade, Needham also announced a price target of $10.
Considering $VRCA closed at $5.11 on Monday, the stated price target suggests a potential upside of $4.89 or approximately 95.50% for $VRCA, as per the view of the brokerage firm.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
DOT, DoW, DHS Join Forces to Protect Southern Border Airspace
October 16th, 2026FTC Sues Ticket Broker Over Unlawful Tactics Used to Buy Millions of Tickets to Popular Live Events
October 15th, 2026October 15th, 2026FDA Approves First Treatment for Certain People With BCG-Unresponsive Bladder Cancer
October 14th, 2026U.S. Treasury Announces Record Enforcement Actions Against Bank of America
October 14th, 2026
Member Login